Management of acute liver failure

Seminars in Liver Disease

Volumn 16, Issue 4, 1996, Pages 369-378

  Lee, William M ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cerebral edema; extracorporeal liver assist devices; liver transplantation; N acetylcysteine; prostaglandins

Indexed keywords

ACETYLCYSTEINE; PARACETAMOL;

BRAIN EDEMA; CLINICAL FEATURE; COMA; DIAGNOSTIC APPROACH ROUTE; DRUG OVERDOSE; EMERGENCY MEDICINE; HUMAN; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; WILSON DISEASE;

EID: 0030464146     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007250     Document Type: Review

References (76)

1. Williams R, Gimson AES: Intensive liver care and management of acute hepatic failure. Dig Dis Sci 36:820-6, 1991
2. Hawker F: Fulminant hepatic failure. In F. Hawker (ed): The Liver. London, W.B. Saunders, 1993, pp 71-135.
3. Lee WM: Medical progress: Acute liver failure. N Engl J Med 329:1862-74.
4. Munoz SJ: Difficult management problems in fulminant hepatic failure. Sem Liv Dis 13:395-413, 1993.
5. Trey C, Davidson CS: The management of fulminant hepatic failure. In Popper H, Schaffner F (eds): Progress in Liver Diseases. New York, Grune and Stratton, 1970, pp 282.
6. Zimmerman HF, Maddrey WC: Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure. Hepatology 22:767-73, 1995.
7. Whitcomb DC, Block GD: Association of acetaminophen heptatotoxicity with fasting and alcohol use. JAMA 272:1845-50, 1994.
8. Henry JA, Jeffreys KJ, Dawling S: Toxictty and deaths from 3,4-methylene-dioxymethamphetamine ("Ecstasy"). Lancet 340:384-7, 1992.
9. O'Grady JG, Alexander GJM, Hayllar KM, Williams R: Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97:439-45, 1989.
10. Mitchell JR, Jollow DJ, Potter WZ, et al: Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharm Exp Therapeut 187:211-17, 1973.
11. Douglas AP, Hamlyn AN, James O: Controlled trial of cysteamine in treatment of acute paracetamol (acetaminophen) poisoning. Lancet 1:111-15, 1976.
12. Prescott LF, Sutherland GR, Park J, et al: Cysteamine, methionine and penicillamine in the treatment of paracetamol poisoning. Lancet 2:109-13, 1976.
13. Prescott LF, Illingworth RN, Critchley JAJH, et al: Intravenous N-acetyl cysteine: the treatment of choice for paracetamol poisoning. BMJ ii:1097-1100, 1979.
14. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH: Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. N Engl J Med 319:1557-62, 1988.
15. Harrison PM, Keays R, Bray GP, et al: Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 335:1572-3, 1990.
16. Keays R, Harrison PM, Wendon JA, et al: A prospective controlled trial of intravenous N-acetylcysteine in paracetamol-induced fulminant hepatic failure. BMJ 303:1024-9, 1991.
17. Vale JA, Proudfoot AT: Paracetamol (acetaminophen) poisoning. Lancet 346:547-52, 1995.
18. Klein AS, Hart J, Brems JJ, et al: Amanita poisoning: treatment and the role of liver transplantation. Am J Med 86:187-93, 1989.
19. Pinson CW, Daya MR, Banner KG, et al: Liver transplantation for severe Amanita phalloides mushroom poisoning. Am J Surg 159:493-9, 1990.
20. Baerg RD, Kimberg DV: Centrilobular hepatic necrosis and acute renal failure in glue sniffers. Ann Intern Med 73:713-20, 1970.
21. Zimmerman HJ: Syndromes of environmental hepatotoxicity. In Hepatotoxicity. The adverse effects of drugs on the liver. New York, Appleton Century Crofts, 1978, pp 279-302.
22. Ruprah M, Mani TGK, Flanagan RJ: Acute carbon tetrachloride poisoning in 19 patients: implications for diagnosis and treatment. Lancet 1:1027-9, 1985.
23. Roche-Sicot J, Benhamou JP: Acute intravascular hemolysis and acute liver failure associated as the first manifestations of Wilson's disease. Ann Intern Med 86:301-3, 1977.
24. McCullough AJ, Fleming DR, Thistle JL, et al: Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 84:161-7, 1983.
25. Berman DH, Leventhal RI, Gavaler JS, et al: Clinical differentiation of fulminant Wilsonian hepatitis from other causes of fulminant hepatic failure. Gastroenterology 100:1129-34, 1991.
26. Kaymakcalan H, Dourdourekas D, Szanto PB, Steigmann F: Congestive heart failure as a cause of fulminant hepatic failure. Am J Med 65:384-8, 1978.
27. Kisloff B, Schaffer G: Fulminant hepatic failure secondary to congestive heart failure. Dig Dis Sci 21:895-900, 1976.
28. Nouel O, Henrion J, Bernuau J, et al: Fulminant failure due to transient circulatory failure in patients with chronic heart disease. Dig Dis Sci 25:49-52, 1980.
29. Huffman BJ, Pate MB, Marsh WH, Lee WM: Cardiomyopathy unrecognized as a cause of hepatic failure. J Clin Gastroenterol 12:306-9, 1990.
30. Sawabe M, Kato Y, Ohashi I, Kitagawa T: Diffuse intrasinusoidal metastasis of gastric carcinoma to the liver leading to fulminant hepatic failure. Cancer 65:169-73, 1990.
31. Karl MM: Hepatic encephalopathy in a 40-yr-old woman. Clinicopathologic conference. Ludmerer KM, Kissane JM, eds. Am J Med 90:374-80, 1991.
32. Krauss EA, Ludwig PW, Sumner HW: Metastatic carcinoma presenting as fulminant hepatic failure. Am J Gastroenterol 72:651-4, 1979.
33. Zafrani ES, Leclercq B, Vernant JP, et al: Massive blastic infiltration of the liver: a cause of fulminant hepatic failure. Hepatology 3:428-32, 1983.
34. Sandle GI, Layton M, Record CO, Cowan WK: Fulminant hepatic failure due to Budd-Chiari syndrome. Lancet 1:1199, 1980.
35. Rolfes DB, Ishak KG: Acute fatty liver of pregnancy: a Clinicopathologic study of 35 cases. Hepatology 5:1149-58, 1985.
36. Riely CA, Latham PS, Romero R, Duffy TP: Acute fatty liver of pregnancy. A reassessment based on observations in nine patients. Ann Intern Med 106:703-6, 1987.
37. McKenzie R, Fried MW, Sallie R, et al: Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333:1099-1105, 1995
38. Weinstein L: Pre-eclampsia/eclampsia with hemolysis, elevated liver enzymes and thrombocytopenia. Obstet Gynecol 66:657-660, 1985.
39. Barton JR, Riely CA, Adamec TA, et al: Hepatic histologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 167:1538-43, 1992.
40. Gonzalez GD, Rubel HR, Giep NN, Bottsford JE: Spontaneous hepatic rupture in pregnancy management with hepatic artery ligation. South Med J 77:242-5, 1984.
41. Loevinger EH, Vujic I, Lee WM, Anderson MC: Hepatic rupture associated with pregnancy: treatment with transcatheter embolotherapy. Obstet Gynecol 65:281, 1985.
42. Ockner SA, Brunt EM. Cohn SM, et al: Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology 11:59-64, 1990.
43. Usta IM, Barton JR, Amon EA, et al: Acute fatty liver of pregnancy: an experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol 171:1342-7, 1994.
44. Benhamou JP, Rueff B, Sicot C: Severe hepatic failure: a critical study of current therapy. In Orlandi F, Jezequel AM (ed): Liver and Drugs. New York, Academic Press, 1972 pp 213.
45. Ware AJ, Jones RE, Shorey JW, Combes B: A controlled trial of steroid therapy in massive hepatic necrosis. Am J Gastroenterol 62:130-3, 1974.
46. EASL Study Group: Randomised trial of steroid therapy in acute liver failure. Gut 20:620-3, 1979.
47. Rakela J, Mosley JW, Edwards VM, et al: A double-blind randomized trial of hydrocortisone in acute hepatic failure. Dig Dis Sci 36:1223-8, 1991.
48. Hughes RD, Wendon J, Gimson AES: Acute liver failure. Gut suppl::S86-9, 1991.
49. Denis J, Opolon P, Nusinovici V, et al: Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut 19-787-93, 1978.
50. Rakela J, Kurtz SB, McCarthy JT: Postdilution hemofiltration in the management of acute hepatic failure: a pilot study. Mayo Clin Proc 63:113-18, 1988.
51. Shin K, Nagai Y, Hirano C, et al: Survival rate in children with fulminant hepatitis improved by a combination of twice daily plasmapheresis and conservative therapy. J Ped Gastroenterol 9:163-9, 1989.
52. Ramos CP, Almario JS: Hemodialysis-hemopertusion in fulminant viral hepatitis. Biomat Art Cells, Art Organs 18:689-92, 1990.
53. Davenport A, Will EJ, Davidson AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 21:323-8, 1993.
54. Larsen FS, Almdal T, Vilstrup H, Tygstrup N: High volume plasma exchange in fulminant hepatic failure. Int J Artific Organs 15:669-76, 1992.
55. O'Brien CJ, Wise RJS, O'Grady JG, Williams R: Neurological sequelae in patients recovered from fulminant hepatic failure. Gut 28:93-5, 1987.
56. Davenport A, Will EJ, Davison AM: Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen selfpoisoning. Cnt Care Med 18.286-9, 1990.
57. MacNaughton PD, Evans TW: Management of adult respiratory distress syndrome. Lancet 339:469-71, 1992.
58. Bihari D, Gimson AES, Waterson M, Williams R: Tissue hypoxia in fulminant hepatic failure. Crit Care Med 13:1034-9, 1985.
59. Bihari DJ, Gimson AES, Williams R: Cardiovascular, pulmonary and renal complications of fulminant hepatic failure. Semin Liver Dis 6:119-28, 1986.
60. Harrison PM, Wendon JA, Gimson AES, et al: Improvement by aceryl cysteine of hemodynamics and oxygen transport in fulminant hepatic failure. New Engl J Med 324:1852-7, 1991.
61. Ringe B, Lubbe N, Kuse E, et al: Management of emergencies before and after liver transplantation by early total hepatectomy. Transplant Proc 235:1090, 1993.
62. Rozga J, Podesta L, LePage E, et al: Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 342:898-9, 1993.
63. So SKS, Barteau GA, Perdrizet GA, Marsh JW: Successful retransplantation after a 48-hour anhepatic state. Transplant Proc 25:1962-3, 1993.
64. Lee WM: Total hepatectomy for acute liver failure: don't take out my liver! Gastroenterology 107:894-7, 1994.
65. 2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Lancet i:617-19, 1977.
66. 2 receptor antagonists in the prevention of upper gastro-intestinal hemorrhage in fulminant hepatic failure. Gastroenterology 4:464-5, 1978.
67. Gazzard B, Henderson J, Williams R: Early changes in coagulation following paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut 16:617-20, 1975.
68. Bihari D, Gimson AE, Lindridge J, Williams R: Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J Hepatol 1:405-16, 1985.
69. Bihari D, Wendon J: Tissue hypoxia in fulminant hepatic failure. In Williams R, Hughes RD (eds): Acute Liver Failure: Improved Understanding and Better Therapy. London, Miter Press, 1991, pp42-4.
70. Wendon JA, Harrison PM, Keays R, et al: Effects of vasopressor agents and epoprostenol on systemic hemodynamics and oxygen transport in fulminant hepatic failure. Hepatology 15:1067-71, 1992.
71. Shoemaker W, Kram HB, Appel PL: Therapy of shock based on pathophysiology, monitoring, and outcome prediction. Crit Care Med 183:19-25, 1990.
72. Rosenbloom AJ: Massive ST-segment elevation without myocardial injury in a patient with fulminant hepatic failure and cerebral edema. Chest 100:870-2, 1991.
73. Davies MH, Mutimer JD, Lowes J, et al: Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 343:1329-30, 1994.
74. Lee WM, Gailbraith RM, Watt GH, et al: Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology 21:101-5, 1995.
75. Schiødt FV, Bondesen S, Tygstrup N: Serial measurements of plasma Gc-globulin in acetaminophen intoxication. Eur J Gastroemerol & Hepatol 7:635-40, 1995.
76. Madl C, Grimm G, Ferenci PM, et al: Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure. Hepatology 20:1487-94, 1994.